|
Oct 13, 2016
|
TechCrunch - Levchin’s Affirm secures $100M credit line from Morgan Stanley
|
|
|
Sep 08, 2016
|
Tech Insider - The EpiPen isn't the only drug that's more than doubled in price
|
|
|
Sep 07, 2016
|
Tech Insider - Drug prices are back in the spotlight — here are the companies with the most to lose
|
|